CorrespondenceFrom intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative
Cited by (0)
- †
Joint senior authors
Crown Copyright © 2020 Published by Elsevier Ltd. All rights reserved.